ArticleBiotechnology reports (Amsterdam, Netherlands)2025
Scale-down optimization of a robust, parallelizable human induced pluripotent stem cell bioprocess for high-throughput research.
James Colter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.